- Home
- RBNE vs IOBT Comparison
RBNE vs IOBT Comparison
Compare RBNE & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.28
HOLD
Current Price
$0.04
Company Overview
Basic Information| Metric | RBNE | IOBT |
|---|---|---|
| Founded | 2024 | 2014 |
| Country | Cyprus | Denmark |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.5M | 12.7M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | RBNE | IOBT |
|---|---|---|
| Price | $1.28 | $0.04 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $2.25 |
| AVG Volume (30 Days) | 292.4K | ★ 186.6M |
| Earning Date | 04-10-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 26.77 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $42.51 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.67 | $0.03 |
| 52 Week High | $20.57 | $2.79 |
Technical Indicators
Market Signals| Indicator | RBNE | IOBT |
|---|---|---|
| Relative Strength Index (RSI) | 33.90 | 25.94 |
| Support Level | $1.23 | N/A |
| Resistance Level | $1.36 | $0.22 |
| Average True Range (ATR) | 0.11 | 0.02 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 6.31 | 15.92 |
Price Performance
Historical Comparison RBNE
IOBT
About RBNE Robin Energy Ltd.
Robin Energy Ltd is engaged in the ownership and operation of vessels providing seaborne transportation of refined petroleum products and liquefied petroleum gas (LPG). The company operates in two reportable segments: the Tanker segment and the LPG carrier segment.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.